title: Inherited variations in AR, ESR1, and ESR2 genes are not associated with prostate cancer aggressiveness or with efficacy of androgen deprivation therapy.
abstract: BACKGROUND
  Sex steroid hormone receptors mediate essential processes in normal prostate growth and contribute to prostate cancer development.
  
  
  METHODS
  In this study, we investigated the association between common inherited variation of the AR, ESR1, and ESR2 genes and two clinically relevant traits: the risk of developing aggressive prostate cancer and the response to androgen deprivation therapy (ADT) in a hospital-based cohort. A total of 43 tagging single nucleotide polymorphisms covering the loci of AR (n = 4), ESR1 (n = 32), and ESR2 (n = 7) were successfully genotyped in 4,073 prostate cancer cases.
  
  
  RESULTS
  None of these single nucleotide polymorphisms were significantly associated with disease aggressiveness as assessed by the D'Amico risk classification, pathologic stage, or the response to ADT.
  
  
  CONCLUSIONS
  Our results suggest that common genetic variations in AR, ESR1, or ESR2 are not strongly associated with prostate cancer aggressiveness or response to ADT.
  
  
  CONCLUSIONS
  Our study did not find convincing evidence of inherited variations in the major receptors for androgens and estrogens and their associations with prostate cancer traits.
authors.affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA.
authors.forename: Tong
authors.initials: T
authors.lastname: Sun
authors.forename: Gwo-Shu Mary
authors.initials: GS
authors.lastname: Lee
authors.forename: Lillian
authors.initials: L
authors.lastname: Werner
authors.forename: Mark
authors.initials: M
authors.lastname: Pomerantz
authors.forename: William K
authors.initials: WK
authors.lastname: Oh
authors.forename: Philip W
authors.initials: PW
authors.lastname: Kantoff
authors.forename: Matthew L
authors.initials: ML
authors.lastname: Freedman
mesh_terms: D047628:Estrogen Receptor alpha / Q000235:genetics*; D047629:Estrogen Receptor beta / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D005838:Genotype; D006801:Humans; D008297:Male; D009361:Neoplasm Invasiveness; D020641:Polymorphism, Single Nucleotide; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000473:pathology / Q000601:surgery; D011944:Receptors, Androgen / Q000235:genetics*; D012307:Risk Factors
chemical_list: C506487:ESR1 protein, human; D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D011944:Receptors, Androgen